Skip to main content
Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,725.00
-3.50 (-0.20%)
At close: Mar 9, 2026

Genmab Revenue

In the year 2025, Genmab had annual revenue of $3.72B USD with 19.19% growth. Genmab had revenue of $1.06B in the quarter ending December 31, 2025, with 3.03% growth.

Revenue
$3.72B
Revenue Growth
+19.19%
P/S Ratio
4.49
Revenue / Employee
$1.25M
Employees
2,973
Market Cap
106.28B DKK

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.72B599.00M19.19%
Dec 31, 20243.12B731.00M30.59%
Jan 1, 20242.39B305.95M14.68%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk 309.06B
Coloplast 27.89B
ALK-Abelló 6.31B
Demant 22.97B
H. Lundbeck 24.63B
Ambu A/S 6.09B
Zealand Pharma 9.21B
Bavarian Nordic 6.89B
Revenue Rankings

Genmab News

More News